These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 25812756)
41. Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation. van Weel V; van Tongeren RB; van Hinsbergh VW; van Bockel JH; Quax PH Ann Vasc Surg; 2008; 22(4):582-97. PubMed ID: 18504100 [TBL] [Abstract][Full Text] [Related]
42. Treatment of peripheral arterial disease using stem and progenitor cell therapy. Lawall H; Bramlage P; Amann B J Vasc Surg; 2011 Feb; 53(2):445-53. PubMed ID: 21030198 [TBL] [Abstract][Full Text] [Related]
43. Human Stem Cells Overexpressing miR-21 Promote Angiogenesis in Critical Limb Ischemia by Targeting CHIP to Enhance HIF-1α Activity. Zhou Y; Zhu Y; Zhang L; Wu T; Wu T; Zhang W; Decker AM; He J; Liu J; Wu Y; Jiang X; Zhang Z; Liang C; Zou D Stem Cells; 2016 Apr; 34(4):924-34. PubMed ID: 26841045 [TBL] [Abstract][Full Text] [Related]
44. [Angiogenesis and vasculogenesis. Therapeutic strategies for stimulation of postnatal neovascularization]. Kalka C; Asahara T; Krone W; Isner JM Herz; 2000 Sep; 25(6):611-22. PubMed ID: 11076319 [TBL] [Abstract][Full Text] [Related]
45. Angiogenesis and gene therapy in man: dream or reality? Amant C; Berthou L; Walsh K Drugs; 1999; 59 Spec No():33-6. PubMed ID: 10548390 [TBL] [Abstract][Full Text] [Related]
46. Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemia. Iafrati MD; Hallett JW; Geils G; Pearl G; Lumsden A; Peden E; Bandyk D; Vijayaraghava KS; Radhakrishnan R; Ascher E; Hingorani A; Roddy S J Vasc Surg; 2011 Dec; 54(6):1650-8. PubMed ID: 22019148 [TBL] [Abstract][Full Text] [Related]
47. Effect of Intramuscular Administration of Mesenchymal Stem Cells and Erythropoietin on Angiogenesis in Critical Limb Ischemia. Lykov AP; Bondarenko NA; Poveshchenko OV; Kabakov AV; Surovtseva MA; Kim II; Kazakov OV; Poveshchenko AF Bull Exp Biol Med; 2018 May; 165(1):121-126. PubMed ID: 29796803 [TBL] [Abstract][Full Text] [Related]
48. Advances in growth factor delivery for therapeutic angiogenesis. Said SS; Pickering JG; Mequanint K J Vasc Res; 2013; 50(1):35-51. PubMed ID: 23154615 [TBL] [Abstract][Full Text] [Related]
49. Cell therapy in critical limb ischemia: current developments and future progress. Mamidi MK; Pal R; Dey S; Bin Abdullah BJ; Zakaria Z; Rao MS; Das AK Cytotherapy; 2012 Sep; 14(8):902-16. PubMed ID: 22731756 [TBL] [Abstract][Full Text] [Related]
50. pCMV-vegf165 Intramuscular Gene Transfer is an Effective Method of Treatment for Patients With Chronic Lower Limb Ischemia. Deev RV; Bozo IY; Mzhavanadze ND; Voronov DA; Gavrilenko AV; Chervyakov YV; Staroverov IN; Kalinin RE; Shvalb PG; Isaev AA J Cardiovasc Pharmacol Ther; 2015 Sep; 20(5):473-82. PubMed ID: 25770117 [TBL] [Abstract][Full Text] [Related]
51. Angiogenic cell therapy for critical limb ischemia: an update on concepts and trials. Furmston J; Patel AS; Ludwinski F; Zuzel V; Bajwa A; Saha P; Smith A; Modarai B J Cardiovasc Surg (Torino); 2014 Oct; 55(5):641-54. PubMed ID: 24941243 [TBL] [Abstract][Full Text] [Related]
52. [Therapeutic angiogenesis of critical lower limb ischemia. Review of the literature and prospects of research on stem cells]. Di Stefano R; Limbruno U; Barone D; Balbarini A Ital Heart J Suppl; 2004 Jan; 5(1):1-13. PubMed ID: 15253139 [TBL] [Abstract][Full Text] [Related]